Tyra Biosciences Statistics
NASDAQ: TYRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
20.12+0.39 (+1.98%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Tyra Biosciences by the numbers
Tyra Biosciences has a market capitalization of $1.39 billion based on 69.08M shares outstanding. With trailing EPS of $-2.63, Tyra Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.4% below its 50-day average and 30.9% below its 200-day average.
Average daily trading volume is 852.56K shares, or about $17.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TYRA valuation vs. peer median
| Metric | TYRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.39B | $1.36B | +2% |
| Avg. volume | 852.56K | 948.24K | -10% |
Peer median across 8 companies: QURE, URGN, RAPP, PAHC, NBTX, NUVB, ANAB, NRIX.
Valuation
- Market cap
- $1.39B
- EPS (TTM)
- $-2.63
- Shares outstanding
- 69.08M
Price and trading
- Previous close
- 19.73
- Open
- 19.62
- Day range
- 19.62 – 20.44
- 52-week range
- 18.25 – 40.65
- 52-week change
- -4.73%
- Beta
- —
- Volume
- 467.58K
- Average volume
- 852.56K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 1.39B
- Forward Pe
- -6.83
- Eps
- -2.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.65
- Week52 Low
- 18.25
- Avg Volume
- 852.56K
- Shares Outstanding
- 69.08M
- Ma50
- 21.27
- Ma200
- 29.14
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -50.50%
- Pct From52w Low
- 10.25%